This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

I’m back! Sorry for the unannounced break last week, but I was underwater.

May was a terrible month for biotech, but June is (early days) looking better.

To read the rest of this story subscribe to STAT+. Subscribe Log In

See Full Page